Immunoclin (Immunoclin) Beginning Cash Position : $0.10 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Beginning Cash Position?

Immunoclin's Beginning Cash Position for the quarter that ended in Oct. 2014 was $0.10 Mil.

Immunoclin's quarterly Beginning Cash Position increased from Apr. 2014 ($0.05 Mil) to Jul. 2014 ($0.09 Mil) and increased from Jul. 2014 ($0.09 Mil) to Oct. 2014 ($0.10 Mil).

Immunoclin's annual Beginning Cash Position increased from Feb. 2012 ($0.01 Mil) to Jan. 2013 ($0.05 Mil) and increased from Jan. 2013 ($0.05 Mil) to Jan. 2014 ($0.17 Mil).

Immunoclin Beginning Cash Position Historical Data

The historical data trend for Immunoclin's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Beginning Cash Position Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Beginning Cash Position

0.01

0.05

0.17

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Beginning Cash Position	Get a 7-Day Free Trial									-	-	0.05	0.09	0.10

Immunoclin Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Immunoclin Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Immunoclin's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines